Filters
Results 1 - 10 of 3827
Results 1 - 10 of 3827.
Search took: 0.029 seconds
Sort by: date | relevance |
AbstractAbstract
[en] Expression of the cold shock protein Y-box protein 1 (YB-1) is associated with deleterious outcome in various malignant diseases. Our group recently showed that the detection of an 18 kDa YB-1 fragment (YB-1/p18) in human plasma identifies patients with malignant diseases. We now tested the prevalence, clinical, and diagnostic value of YB-1/p18 detection in common tumors. A newly established monoclonal YB-1 antibody was used to detect YB-1/p18 by immunoblotting in plasma samples from 151 unselected tumor patients, alongside established tumor markers and various diagnostic measures, during evaluation for a cancerous disease and in follow-up studies after therapeutic interventions. Circulating YB-1/p18 was detected in 78% of patients having a tumor disease. YB-1/p18 positivity was highly prevalent in all examined malignancies, including lung cancer (32/37; 87%), breast cancer (7/10; 70%), cancer of unknown primary (CUP; 5/5, 100%) or hematological malignancies (42/62; 68%). Positivity for YB-1/p18 was independent of other routine laboratory parameters, tumor stage, or histology. In comparison to 13 established tumor markers (cancer antigens 15–3, 19–9, 72–4, and 125; carcinoembryonic antigen; cytokeratin fragments 21–1; neuron-specific enolase; alpha-fetoprotein; beta-2-microglobulin; squamous cell carcinoma antigen; thymidine kinase; tissue polypeptide antigen; pro-gastrin-releasing peptide), YB-1/p18 detection within serum samples was the most sensitive general parameter identifying malignant disorders. YB-1/p18 concentrations altered during therapeutic interventions, but did not predict prognosis. Plasma YB-1/p18 detection has a high specific prevalence in malignancies, thereby providing a novel tool for cancer screening independent of the tumor origin
Primary Subject
Source
Available from http://dx.doi.org/10.1186/1471-2407-14-33; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909385; PMCID: PMC3909385; PUBLISHER-ID: 1471-2407-14-33; PMID: 24443788; OAI: oai:pubmedcentral.nih.gov:3909385; Copyright (c) 2014 Tacke et al.; licensee BioMed Central Ltd.; This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0) (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
BMC cancer (Online); ISSN 1471-2407;
; v. 14; p. 33

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
External URLExternal URL
AbstractAbstract
[en] Full text: Objective: To assess and compare the overall value of pleural fluid CEA and CYFRA 21-1 in differential diagnosis of pleural effusions with a meta-analysis. Methods: All the English and Chinese published studies for differential diagnosis of pleural effusions by pleural fluid CEA and CYFRA 21-1 were collected. Methodological quality of the included studies was then evaluated. Pooled sensitivity and specificity were calculated, the threshold effect and the possible sources of heterogeneity were also analyzed. SROC (summary receiver operating characteristic) was used to compare the differential diagnostic ability of pleural fluid CEA and CYFRA 21-1. Results: 19 studies were included in the meta-analysis, with a total of 3228 subjects. Pooled sensitivity and specificity of CEA and CYFRA 21-1 were 45.9%(43.2%- 48.5%),97.0%(96.0%-97.8%) and 47.3%(44.0%- 50.6%),91.8%(89.5%-93.7), respectively. Both CEA and CYFRA 21-1 have a threshold effect, the main source of heterogeneity was from variable assay methods. AUC (area under the curve) of CEA and CYFRA 21-1 were 0.7691 and 0.8213, respectively. There was no statistical significance between the AUC of CEA and CYFRA 21-1 (p>0.05). Conclusion: Both CEA and CYFRA 21-1 have good performance at differential diagnosis of pleural effusion, while compared with CEA, CYFRA 21-1 has no advantage. (author)
Primary Subject
Source
ICRT-2007: 2. international conference on radiopharmaceutical therapy; Ulaanbaatar (Mongolia); 3-7 Sep 2007; Annual conference of Asia Regional Cooperative Council for Nuclear Medicine (ARCCNM); Ulaanbaatar (Mongolia); 3-7 Sep 2007; Also available on-line: www.wjnm.org; Available in abstract form only, full text entered in this record
Record Type
Journal Article
Literature Type
Conference
Journal
World Journal of Nuclear Medicine; ISSN 1450-1147;
; v. 6(suppl.1); p. S93-S94

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Bachman, S.; Gieszczynska, J.; Pietka, M.
Materials of 9. national conference of Maria Sklodowska-Curie Polish Radiation Research Society1992
Materials of 9. national conference of Maria Sklodowska-Curie Polish Radiation Research Society1992
AbstractAbstract
[en] Short communication
Original Title
Radiacyjna detoksykacja niepozadanych zwiazkow chemicznych w zywnosci
Secondary Subject
Source
Polskie Towarzystwo Badan Radiacyjnych im. Marii Sklodowskiej-Curie, Warsaw (Poland); 88 p; 1992; p. 4; Institute of Nuclear Physics; Cracow (Poland); 9. National conference of Maria Sklodowska-Curie Polish Radiation Research Society; 9. Krajowy zjazd Polskiego Towarzystwa Badan Radiacyjnych im. Marii Sklodowskiej-Curie; Krakow (Poland); 2-3 Apr 1992; Available from Institute of Nuclear Physics, Cracow (PL)
Record Type
Miscellaneous
Literature Type
Conference
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] To assess and identify the causes and circumstances leading to delays in health seeking and diagnosis of tuberculosis patients as they often present with advance disease resulting in increased morbidity and mortality. Settings Department of Tuberculosis, DOTS clinic DHQ Hospital, Vehari. Methodology One (author) inspiration diagnosed smear positive pulmonary tuberculosis patients were included. Information was gathered through interviews and from TB-01 card. Results Maximum patients were in age group of 16-40 years. Median patient delay was 4-6 months; jobless, homeless personnel had longer delay. The main reason for delay was that the symptoms were not considered serious enough. Delay in presentation of smear positive cases may be due to the lack of awareness of patients and the incompetence of some health workers. Training and supervision of staff and awareness campaigns targeted at the population and involvement of private sector will improve TB control in Vehari. (author)
Primary Subject
Record Type
Journal Article
Journal
Infection Diseases Journal; ISSN 1027-0299;
; v. 19(1); p. 144-147

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
No abstract available
Original Title
Irradiation des produits alimentaires pulverulents
Primary Subject
Source
16 refs.
Record Type
Journal Article
Journal
Food Irradiation Information; (no. 1); p. 23-27
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
Dabeka, R.W.
IAEA-NBS international workshop. Practical analytical approaches to the assessment of human dietary intake of nutrients, toxic constituents and radionuclides1987
IAEA-NBS international workshop. Practical analytical approaches to the assessment of human dietary intake of nutrients, toxic constituents and radionuclides1987
AbstractAbstract
[en] Short communication. 8 refs
Primary Subject
Source
International Atomic Energy Agency, Vienna (Austria); National Bureau of Standards, Gaithersburg, MD (USA); 57 p; Oct 1987; p. 23-24; IAEA-NBS international workshop on practical analytical approaches to the assessment of human dietary intake of nutrients, toxic constituents and radionuclides; Gaithersburg, MD (USA); 2 Oct 1987
Record Type
Report
Literature Type
Conference
Report Number
Country of publication
Reference NumberReference Number
Related RecordRelated Record
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The clinicopathological features and prognosis of gastric cancer in young patients are both limited and controversial. Therefore, the aim of this study was to define the clinicopathological features and prognosis of gastric cancer in young patients after curative resection. From May 2008 to December 2014, 198 young patients (age ≤ 40 years) and 1096 middle-aged patients (55 ≤ age ≤ 64 years) were enrolled in this study. The clinicopathological features and prognosis of gastric cancer in these patients were analyzed. Compared with middle-aged patients, the proportion of females, lower third tumors, tumor size less than 5 cm, poorly differentiated tumors and T1 tumors were significantly higher in young patients (all P < 0.05). The proportions of comorbidity, upper third tumors, well and moderately differentiated tumors, T4 tumors, and positive carcinoembryonic antigen (CEA), alpha fetoprotein (AFP) and carbohydrate antigen (CA) 19–9 were significantly lower in young patients (all P < 0.05). The distributions of N status and CA125 were comparable between young and middle-aged patients (all P > 0.05). The five-year overall survival rates were comparable between young patients and middle-aged patients (62.8 vs 54.7 %, P = 0.307). The tumor location, T status, N status and CA125 were independent predictors of prognosis in young patients. The overall survival of patients with tumors located in the upper or middle third was significantly lower than for those located in the lower third (60.8 vs 50.6 % vs 68.4 %, P = 0.016). The overall survival of CA125-positive patients was significantly lower than CA125-negative patients (49.0 vs 64.4 %, P = 0.001). The clinicopathological features were significantly different between young and middle-aged patients. The prognosis of gastric cancer in young patients was equivalent to that of middle-aged patients. Tumor location, T status, N status and CA125 were independent risk factors for prognosis in young patients. The online version of this article (doi:10.1186/s12885-016-2489-5) contains supplementary material, which is available to authorized users
Primary Subject
Source
Available from http://dx.doi.org/10.1186/s12885-016-2489-5; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946107; PMCID: PMC4946107; PMID: 27418046; PUBLISHER-ID: 2489; OAI: oai:pubmedcentral.nih.gov:4946107; Copyright (c) The Author(s). 2016; Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.; Country of input: International Atomic Energy Agency (IAEA)
Record Type
Journal Article
Journal
BMC cancer (Online); ISSN 1471-2407;
; v. 16; vp

Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
External URLExternal URL
AbstractAbstract
No abstract available
Original Title
Eine Datenbank fuer Vergiftungen
Primary Subject
Secondary Subject
Source
4 figs.; 1 tab.; 7 refs.
Record Type
Journal Article
Journal
Kerntechnik; v. 15(2); p. 65-71
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] The paper tries to illustrate the analogies as well as the differences between ionizing radiation and chemotoxic agents with regard to their adverse somatic effects and the concepts for the determination of limiting values for dose or concentration. On the basis of experience on the cancerogenic and genetic effects of ionizing radiation, the limiting radiation doses for the population were set so low that acute harmful effects of radiation are ruled out. The legal concentration limiting values for many non-mutagenic chemical pollutants, on the other hand, are often based on nothing but a comparison with their acute effects, with the assumption that there is a threshold concentration. This concept is discussed by the example of different pollutants and compared with the natural and man-made level of these pollutants. The findings show that acute effects of chemical pollutants leading to increased morbidity and even mortality of the general population under adverse conditions cannot be ruled out. The assessment of the delayed effects of ionizing radiation and chemical pollutants poses the same problems. Epidemiological statistics suggest that artificial and also natural cancerogenics, have a significant influence on the cancer incidence. Animal experiments show that for ionizing radiation as well as for chemical cancerogenics, the mean latency period for cancer lengthens with decreasing dose. (orig./AK)
[de]
In dem Vortrag wird versucht, sowohl die Analogien als auch die Unterschiede aufzuzeigen, die zwischen ionisierenden Strahlen und chemotoxischen Stoffen hinsichtlich ihrer somatischen Schadwirkungen und der Konzepte zur Festlegung von Dosis- bzw. Konzentrationsgrenzwerten fuer diese Agentien bestehen. Aufgrund der Erfahrungen ueber die kanzerogene und genetische Wirksamkeit ionisierender Strahlen wurden die hoechstzugelassenen Strahlendosen fuer die Bevoelkerung so niedrig festgelegt, dass akute schaedliche Strahlenwirkungen mit Sicherheit nicht auftreten. Bei vielen nichtmutagenen, chemischen Schadstoffen hingegen beruhen die derzeit gueltigen Konzentrationsgrenzwerte allein auf einem Vergleich mit ihrer akuten Wirksamkeit, wobei die Existenz einer Schwellenkonzentration angenommen wird. Am Beispiel verschiedener Luftverunreinigungen wird dieses Konzept diskutiert und mit dem natuerlichen und zivilisatorischen Pegel dieser Schadstoffe verglichen. Danach sind bei unguenstigen Bedingungen akute Wirkungen chemischer Schadstoffe auf die Bevoelkerung die nicht nur eine erhoehte Morbiditaet, sondern auch eine erhoehte Mortalitaet ausloesen koennen, nicht auszuschliessen. Bei der Beurteilung der Spaetwirkungen treten bei ionisierenden Strahlen und chemischen Schadstoffen die gleichen Probleme auf. Epidemiologische Erhebungen lassen vermuten, dass nicht nur zivilisationsbedingte, sondern auch natuerlicherweise vorkommende Kanzerogene einen signifikanten Einfluss auf die Krebshaeufigkeit haben. Tierexperimente weisen daraufhin, dass sowohl bei ionisierenden Strahlen als auch bei kanzerogenen Chemikalien die mittlere Krebsinduktionszeit mit sinkender Dosis zunimmt. (orig./ORU)Original Title
Ueber das somatische Risiko durch radiologische und chemische Umwelteinfluesse
Primary Subject
Secondary Subject
Source
Fachverband fuer Strahlenschutz e.V., Karlsruhe (F.R. Germany); Vereinigung Deutscher Strahlenschutzaerzte e.V., Muenchen (F.R. Germany); p. 35-59; 1974; Annual meeting of the Fachverband fuer Strahlenschutz e.V. in cooperation with the Vereinigung Deutscher Strahlenschutzaerzte e.V; Helgoland, F.R. Germany; 23 Sep 1974; 9 figs.; 20 refs. Available from ZAED.
Record Type
Report
Literature Type
Conference
Report Number
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
AbstractAbstract
[en] Tumour marker analysis has increased our understanding of the presence of tumours in the body. Carcino-embryonic antigen, CEA, is one of the best studied tumour markers and has proved an ideal diagnostic adjuvant. It has helped in quantifying the amount of disease present in a patient and thence to make accurate prognosis on the various diagnosed ailments. At UCH, it is observed that there is an increase in cancer related ailments and therefore the need for early diagnosis is more compelling in our environment to mitigate future cost of managing advanced manifestation
Primary Subject
Source
Feb 1999; 12 p; UCH; Ibadan (Nigeria); National symposium on cancer screening for chief executives in private and public sectors; Lagos (Nigeria); 17 Feb 1999; ALSO AVAILABLE FROM PROF. O. AKUTE, (COLLEGE OF MEDICINE, UNIVERSITY OF IBADAN, IBADAN (NG))
Record Type
Miscellaneous
Literature Type
Conference
Report Number
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue
1 | 2 | 3 | Next |